HPV 16/18 Assay
Product Overview
The EasyNAT® HPV 16/18 Assay is an automated, in vitro nucleic acid amplification test for the qualitative detection of high risk of types HPV 16 and 18 DNA in female endocervical and genitourinary specimens.
- Results available within: 51 minutes
Designed to provide an accurate LOD: 1000 copies/mL
Identify HPV 16 and 18 high-risk types in female endocervical and genitourinary specimen
Ongoing Challanges
HPV 16 and 18 are high-risk types responsible for ~70% of all cervical cancers and a significant fraction of other anogenital and oropharyngeal cancers.
The standard model involves a Pap smear or HPV test at a clinic, with samples sent to a central lab contributes to critical delays.
Clinical Value
- In time follow up, take necessary colposcopy/treatment, leading to timely prevent cancer progression.
An mPOC test (providing results in <60 minutes) would be revolutionary by closing the screening care gap.
Allows clinicians to prioritize these patients for immediate, more intensive diagnostic workup, streamlining resource allocation.
